Protara Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
TARA on Nasdaq
Location
345 Park Avenue South, 3 Rd Floor, New York, NY

Insiders trading volume in the past year

Protara Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Opaleye Management Inc. 10%+ Owner $3.4M -$1.75M -34% Sep 11, 2024
Jesse Shefferman CEO and President, Director $2.28M Aug 28, 2024
Jacqueline Zummo Chf Scientific Operations Off $199K Jan 19, 2024
Jathin Bandari Chief Medical Officer $108K Jan 19, 2024
Hannah Fry VP, Controller $57K Jan 19, 2024
Patrick Fabbio Chief Financial Officer $42K Jan 19, 2024
Blaine Davis Chief Financial Officer $39.5K Jul 15, 2022
Martin Sebastian Olivo Chief Medical Officer $27.4K Jun 10, 2021
Richard S. Levy Director Jun 7, 2024
Cynthia Smith Director Jun 7, 2024
Michael Edward Solomon Director Jun 7, 2024
Roger Garceau Director Jun 7, 2024
Jane Huang Director Jun 7, 2024
Barry P. Flannelly Director Jun 7, 2024
Gregory Sargen Director Jun 7, 2024
Luke M. Beshar Director Jun 7, 2024

Recent Insider Transactions by Companies or Individuals for Protara Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.